The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of proteomic analysis of LKB1/AMPK/mTOR pathways to identify IGF-1R pathway upregulation with LKB1 loss or mTOR inhibition in NSCLC: Implications for targeted combinations.
Emrullah Yilmaz
No relevant relationships to disclose
Lauren Averett Byers
No relevant relationships to disclose
Lixia Diao
No relevant relationships to disclose
Uma Giri
No relevant relationships to disclose
Jayanthi Gudikote
No relevant relationships to disclose
You Hong Fan
No relevant relationships to disclose
Jing Wang
No relevant relationships to disclose
Kevin R. Coombes
No relevant relationships to disclose
Luc Girard
No relevant relationships to disclose
John D. Minna
No relevant relationships to disclose
John Heymach
No relevant relationships to disclose